Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

LKFT vs PRGO: stock comparison and AI forecast

Lakefront Biotherapeutics Nv (LKFT) and Perrigo Co Plc (PRGO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

LKFT Lakefront Biotherapeutics Nv

Price
$32.15 +13.2% · 6M
Market Cap
$2.12B
P/E Ratio
4.8x
Size
mid-cap
AI Forecast
Full analysis →
NYSE · Pharmaceutical Preparations

PRGO Perrigo Co Plc

Price
$15.70 +34.9% · 6M
Market Cap
$2.18B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-05 → 2026-11-04

Six-month price performance

Closing prices rebased to 100 at the start of the window.

90105120135
LKFT +13.2% PRGO +34.9%
LKFT · PRGO

Key facts

  • LKFT and PRGO have similar market capitalizations ($2.12B and $2.18B).
  • Over the last six months PRGO returned +34.9% and LKFT +13.2%.
  • LKFT turns 18.2% of its revenue into net income, against -41.9% for PRGO.
  • PRGO carries 2.02 times debt per unit of equity, against 0.05 times for LKFT.
  • PRGO yields 7.34% in dividends; LKFT pays none.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricLKFTPRGO
Market Cap$2.12B$2.18B
P/E Ratio4.83x–
P/B Ratio–0.87x
Dividend Yield–7.34%
EPS$6.66$-12.57
Book Value/Share–$18.13
Revenue/Share$36.68$29.87
FCF/Share$-26.83$0.86

Profitability & Margins

MetricLKFTPRGO
ROE12.0%-69.0%
ROA11.4%-22.8%
ROIC-7.7%-23.9%
Gross Margin96.3%33.3%
Operating Margin-11.7%-37.7%
Net Margin18.2%-41.9%
EBT Margin4.1%-38.9%
Tax Rate-9.0%-5.6%

Financial Health

MetricLKFTPRGO
Current Ratio20.15x2.32x
Quick Ratio20.00x1.32x
D/E Ratio0.05x2.02x
Financial Leverage1.05x3.02x
Interest Coverage–-6.4x
Working Capital$3.44B$1.40B

Cash Flow

MetricLKFTPRGO
Operating Cash Flow-$1.68B$196M
Free Cash Flow-$1.77B$119M
Capital Spending-$87M-$77M
OCF Growth YoY–-46.5%
FCF Growth YoY–-53.5%
FCF/Sales-73.2%2.9%
CapEx/Sales3.6%1.9%

Operational Efficiency

MetricLKFTPRGO
Asset Turnover0.63x0.54x
Receivables Turnover103.0x5.8x
Inventory Turnover3.5x2.6x
Fixed Assets Turnover29.6x4.9x
Days Sales Outstanding4 days63 days
Days Inventory105 days140 days
Payables Period488 days53 days
Cash Conversion Cycle-379 days150 days

Income Statement

MetricLKFTPRGO
Total Revenue$2.42B$4.14B
Operating Income-$282M-$1.56B
Net Income$440M-$1.73B
R&D Expense$1.76B$95M
SG&A Expense–$1.03B
Cost of Goods Sold$89M$2.77B

Dividend & Shareholder Information

MetricLKFTPRGO
Dividends Per Share–$1.15
Shares Outstanding66M139M
FAQ

LKFT vs PRGO: stock comparison and AI forecast

Which is bigger, LKFT or PRGO?

LKFT and PRGO have similar market capitalizations ($2.12B and $2.18B).

Which stock performed better over the last six months, LKFT or PRGO?

Over the last six months PRGO returned +34.9% and LKFT +13.2%.

Which one does Intratio's AI model rank higher, LKFT or PRGO?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.